Unlocking the Future of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the minimally invasive glaucoma surgery (migs) devices market?
The market size of minimally invasive glaucoma surgery (MIGS) devices has seen enormous growth in recent times. The projection is for it to increase from $0.7 billion in 2024 to $0.9 billion in 2025, with a compound annual growth rate (CAGR) of 28.3%. The prime factors for the significant growth during the historical period include enhanced understanding of blindness prevention, greater investments in healthcare infrastructure, elevated patient knowledge about cutting-edge vision correction treatments, and increased government initiatives.
What will be the minimally invasive glaucoma surgery (migs) devices market size in the future?
In the coming years, the market size of minimally invasive glaucoma surgery (MIGS) devices is predicted to experience a substantial expansion. It is projected to reach a value of $2.42 billion in 2029, with a compound annual growth rate (CAGR) of 28.1%. Factors contributing to this growth during the forecast period include the rising incidence of eye conditions such as glaucoma, an increasing elderly population, the evolution of the healthcare infrastructure, and the mounting requirement for safer, more effective treatments. Key trends during the estimated period are the adoption of MIGS devices, technology advancements, the creation of inventive minimally invasive glaucoma surgery devices, the development of state-of-the-art implantable devices, and progress in ophthalmic technology.
Get your minimally invasive glaucoma surgery (migs) devices market report here!
What main drivers are fueling expansion in the minimally invasive glaucoma surgery (migs) devices market?
The surge in eye disorder cases is anticipated to drive the expansion of the minimally invasive glaucoma surgery (MIGS) devices market. Eye conditions encompass a broad spectrum of issues that impact vision and eye health. The rise in such disorders can be attributed to lifestyle alterations, environmental factors, and aging populations. Minimally invasive glaucoma surgery (MIGS) devices are cutting-edge instruments employed in treating a variety of eye illnesses, with an emphasis on minimizing intraocular pressure (IOP) to halt or manage the advancement of glaucoma. For instance, the National Eye Institute, a US-based government agency, projects that by 2030, approximately 2.2 million Americans will be blind or have impaired vision. Thus, the rise in eye disorders is fueling the growth of the minimally invasive glaucoma surgery (MIGS) devices market.
What key areas define the segmentation of the global minimally invasive glaucoma surgery (migs) devices market?
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
Who are the dominant players expanding their reach in the minimally invasive glaucoma surgery (migs) devices market?
Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.
What emerging trends are influencing the growth of the minimally invasive glaucoma surgery (migs) devices market?
Major corporations in the market of minimally invasive glaucoma surgery (MIGS) devices are channeling their efforts towards the innovation of new products like stent injectable systems to fill the gaps in glaucoma management and enhance the results for patients. The stent injectable system, a MIGS device, administers and inserts a tiny stent into the body through a process similar to injection, often utilizing a distinct delivery method typically used in minimally invasive surgeries for conditions like blocked or constricted blood vessels. As an example, the Glaukos Corporation, an ophthalmic medical technology firm based in the US, gained 510(k) clearance from the U.S. Food and Drug Administration (FDA) in August 2022 for their iStent Infinite Trabecular Micro-Bypass System. The innovative iStent Infinite is a three-stent injectable system engineered to provide continuous, 24/7 intraocular pressure (IOP) control for patients suffering from primary open-angle glaucoma (POAG) and whose IOP is not managed with previous medication and surgical interventions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15863
Which regions are emerging as leaders in the minimally invasive glaucoma surgery (migs) devices market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Minimally Invasive Surgery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report
Non-Invasive Ventilators Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-invasive-ventilators-global-market-report
Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
